Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous v3.5.0. No changes to study details or related content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed on the page.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice regarding the lapse in government funding and the NIH Clinical Center status has been added, and the page shows a revision note updating from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedAdds: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removes: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.